Strategic Investment & Partnership Platform

Connecting Ideas,

Capital and

Opportunities.

Leapsun Partners builds bridges between innovation, industries, and global growth opportunities.

Scroll to explore
About Leapsun

A New Paradigm in Strategic Partnership

Leapsun Partners is a strategic platform focused on connecting people, capital, and transformative ideas. We operate at the intersection of global markets, emerging industries, and long-term value creation.

Our approach is built on deep industry expertise, trusted relationships, and a relentless focus on building partnerships that endure.

30+
Years of Experience
50+
Global Partners
5
Focus Sectors
Strategic partnership
Leapsun Partners · Singapore
"

Connecting Ideas, Capital and Opportunities.

Core Mission
Our Expertise

Where We Create Value

Five domains where we identify, connect and accelerate transformative opportunities.

01
01

Healthcare

Investing in next-generation healthcare systems and medical innovation across emerging markets.

02
02

Biotechnology

Partnering with pioneering biotech ventures transforming life sciences and therapeutics.

03
03

Emerging Technology

Identifying and accelerating high-potential technology opportunities shaping tomorrow.

04
04

Cross-border Investments

Facilitating capital flows and strategic alignments across international markets.

05
05

Strategic Partnerships

Forging alliances between corporates, governments, and innovators to unlock shared potential and create powerful synergies across borders and industries.

Portfolio

Strategic Focus Across Innovation Frontiers

Pioneering companies that reshape their industries through technological innovation, clinical insight, and data-driven precision.

Healthcare & Longevity Tech
1
Category 1

Healthcare & Longevity Tech

Technology-driven companies aligned with regulatory pathways, clinical application, and long-term public health goals.

Angelexo

Angelexo

Brain-Computer Interface & Neuro-Rehab Robotics

Pioneers non-invasive brain-computer interface (BCI) technology integrated with neuro-rehabilitation robotics. Developing intelligent human-machine interaction systems that decode neural signals to drive motor rehabilitation for stroke survivors and neurological disorder patients. Translates cutting-edge BCI science into clinical-grade recovery solutions.

Pegbio

Pegbio

派格生物
Long-Acting Biologics

Targets diabetes, obesity, and metabolic disease with differentiated long-acting GLP-1 receptor agonists. Core product PB-119 is NDA-stage, leading China's innovative approach to chronic disease prevention.

BDgene

BDgene

本导基因
In Vivo CRISPR Gene Editing

Pioneers in vivo CRISPR/Cas9 gene editing via proprietary VLP and lentiviral delivery platforms. Lead program BD111 — the world's first CRISPR antiviral therapeutic targeting herpetic stromal keratitis — holds FDA IND clearance, Phase II clinical status, and EU Orphan Drug Designation.

Advanced Technology & Industrial Intelligence
2
Category 2

Advanced Technology & Industrial Intelligence

Foundational technologies enabling national digital infrastructure, industrial upgrading, and operational resilience.

Minisilicon

Minisilicon

米硅科技
Optical Communication Chips

Develops high-speed, high-reliability chips for optical communication and data centers. Supports 400G+ data infrastructures essential for cloud computing and AI scalability.

Hawkeyes

Hawkeyes

禾楷电气
Laser Detection for Power & Industrial Equipment

Self-developed laser detection technology backed by a certified cleanroom photonics lab and multiple invention patents. Serves substations and large industrial enterprises with online monitoring instruments, fault early-warning systems, and end-to-end condition-based maintenance solutions.

SurMeta

SurMeta

申美信息
Making Digital Transformation Verifiable

Drives enterprise intelligence with AI, large models, data intelligence, software engineering, digital twins, AIoT and cloud infrastructure. Delivers industry-specific solutions across finance, automotive, telecom, energy, manufacturing and consumer sectors.

New Consumer & Digital Commerce
3
Category 3

New Consumer & Digital Commerce

Digital-native operators positioned as the intelligent backbone of China's evolving consumer economy.

Keying

Keying

凯诘电商
Full-Stack E-Commerce Operations

China's fifth-largest digital retail solutions provider by GMV. End-to-end services from traffic to fulfillment for 200+ global brands across Tmall, JD.com, Douyin, and Pinduoduo.

Sensilab

Sensilab

尚生力
Vision Healthcare — EU Nutrition Supplement Group

Sensilab is a core brand of Vision Healthcare — the EU's leading nutrition supplement group, headquartered in the Netherlands. Built on evidence-based formulations and strong digital marketing channels, Sensilab serves tens of millions of customers across 40+ countries with a portfolio spanning vitamins & minerals, weight management, and functional health products. Leapsun is a long-term strategic partner driving Sensilab's premium range into the Asia-Pacific and China markets.

Common Traits
Niche but Scalable
Each company addresses a specific unmet need with potential for broad, long-term market adoption.
Tech-Centric with Operational Depth
From chips to biotech, the portfolio emphasizes execution — not just vision.
Strategically Relevant
Focused on longevity, data, and efficiency — three defining themes of the coming decades.
Our Journey

Vision in Motion

2012

Foundation

Leapsun Partners established with a vision to bridge Asia's capital with global innovation ecosystems.

2015

Regional Expansion

Extended presence across Southeast Asia, forging cornerstone partnerships in key emerging markets.

2018

Sector Diversification

Expanded into healthcare and biotechnology, establishing dedicated investment verticals.

2021

Global Platform

Launched integrated cross-border investment platform connecting Asia Pacific with Europe.

2024

Ecosystem Builder

Evolved into a full-spectrum ecosystem builder, cultivating sustainable innovation networks.

2030Upcoming

The Future

Building tomorrow's defining partnerships across health, technology, and sustainable growth.

Insights

Perspectives on Global Growth

The GLP-1 Revolution: Long-Acting Biologics and the Race to Redefine Metabolic Medicine
Healthcare
The 400G+ Race: Optical Communication Chips as the Unseen Engine of AI Infrastructure
Deep Tech
China's 2025 Consumption Recovery: Why Full-Stack E-Commerce Operations Are the New Infrastructure Play
Investment
Europe–Asia Health Brands: Pathways into China's $70B Premium Wellness Market
Markets
Get In Touch

Let's Build the Future Together

We're always looking for exceptional partnerships. Reach out to explore how we can work together.

Singapore
100 Peck Seah Street, PS100 #08-14
Singapore 079333
Shanghai
上海市新金桥路1122号方正大厦1912室
上海 201206